Mitra Rajendra N, Conley Shannon M, Naash Muna I
Department of Cell Biology, University of Oklahoma Health Sciences Center, 940 Stanton L. Young Blvd., BMSB 781, 73104, Oklahoma City, OK, USA.
Adv Exp Med Biol. 2016;854:463-9. doi: 10.1007/978-3-319-17121-0_62.
Oxidative stress plays a role in many different forms of neurodegenerative ocular disease. The imbalance between the generation of endogenous reactive oxygen species (ROS) and their corresponding neutralization by endogenous antioxidant defense systems leads to cellular oxidative stress, oxidation of different bio-macromolecules, and eventually retinal disease. As a result, the administration of supplemental endogenous antioxidant materials or exogenous ROS scavengers is an interesting therapeutic approach for the treatment of forms of ocular disease associated with oxidative stress. Thus far, different dietary antioxidant supplements have been proven to be clinically reliable and effective, and different antioxidant gene therapy approaches are under investigation. In addition, various metal oxide nanoparticles were shown to be effective in defending against oxidative stress-associated injury. These benefits are due to free radical scavenging properties of the materials arising from non-stoichiometric crystal defects and oxygen deficiencies. Here we discuss the application of this approach to the protection of the retina.
氧化应激在多种不同形式的神经退行性眼病中起作用。内源性活性氧(ROS)的产生与内源性抗氧化防御系统对其相应的中和作用之间的失衡会导致细胞氧化应激、不同生物大分子的氧化,最终引发视网膜疾病。因此,给予补充内源性抗氧化物质或外源性ROS清除剂是治疗与氧化应激相关的眼病的一种有趣的治疗方法。到目前为止,不同的膳食抗氧化补充剂已被证明在临床上可靠且有效,并且不同的抗氧化基因治疗方法正在研究中。此外,各种金属氧化物纳米颗粒已被证明在抵御氧化应激相关损伤方面有效。这些益处归因于材料由于非化学计量晶体缺陷和氧缺陷而具有的自由基清除特性。在此我们讨论这种方法在视网膜保护中的应用。